HCRN Directory

Melanoma

Phase II multi-center study of adjuvant nivolumab in combination with ipilimumab in patients with high-risk uveal melanoma

Status

Cancer Types

Melanoma

Locations

Phase II single-arm multi-center study of adjuvant ipilimumab in combination with nivolumab in subjects with high-risk ocular melanoma

Status

Cancer Types

Melanoma

Locations

A Phase III Multicenter Randomized Trial of DTIC, Cisplatin, BCNU and Tamoxifen Versus DTIC Alone in Patients with Metastatic Melanoma

Status

Cancer Types

Melanoma

Locations

Phase II Study of High Dose Cimetidine in Patients with Metastatic Malignant Melanoma

Status

Cancer Types

Melanoma

Locations

Phase II Study of Daily Oral VP-16 in Metastatic Melanoma

Status

Cancer Types

Melanoma

Locations

The combination of PAC-1 and entrectinib for the treatment of metastatic uveal melanoma

Status

Cancer Types

Melanoma

Locations

A Phase III Multicenter Randomized Trial of the Dartmouth Regimen Versus Dacarbazine Alone in Patients with Metastatic Melanoma

Status

Cancer Types

Melanoma

Locations

Phase II Trial of Cimetidine in Metastatic Melanoma

Status

Cancer Types

Melanoma

Locations

HCRN-MEL16-252

Single Arm Phase II Study of Ipilimumab and Nivolumab as Adjuvant Therapy for Resected Mucosal Melanoma (SALVO Study). HCRN: MEL16-252

Status

Open to Accrual

Cancer Types

Melanoma

Locations

Fox Chase Cancer Center, Iowa, Masonic Cancer Center, University of Minnesota, Mayo Clinic, Minnesota, Nebraska, Nebraska Cancer Specialists, Oregon, Pennsylvania, Providence Cancer Institute, University of Iowa Holden Comprehensive Cancer Center

HCRN-MEL17-309

Phase II single-arm multi-center study of adjuvant ipilimumab in combination with nivolumab in subjects with high-risk ocular melanoma

Status

Open to Accrual

Cancer Types

Melanoma

Locations

California, Columbia University Irving Medical Center, Georgetown Lombardi Comprehensive Cancer Center, Illinois, MD Anderson Cancer Center, Missouri, New York, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, Texas, UC San Francisco, Washington, D.C.

HCRN-MEL16-261

MMP-01: Pilot Study Evaluating Activity of the Combination of Anti-PD-1 Antibody With High Dose IL-2 in Metastatic Melanoma

Status

Closed

Cancer Types

Melanoma

Locations

MMP-MEL18-372

Phase 1B/2 Study of PAC-1 and Entrectinib for Patients with Metastatic Uveal Melanoma

Status

Closed

Cancer Types

Melanoma

Locations

HCRN-MEL91-1

A Phase III Study Comparing Cisplatin, Dacarbazine, Carmustine and Tamoxifen vs Dacarbazine Alone in Patients with Advanced Melanoma

Status

Closed

Cancer Types

Melanoma

Locations

HCRN-MEL90-1

Phase II Trial of Carboplatin plus Interferon Alpha-2a in Metastatic Melanoma

Status

Closed

Cancer Types

Melanoma

Locations

HCRN-MEL89-1

Phase II Study of Daily Oral VP-16 in Previously Untreated Melanoma

Status

Closed

Cancer Types

Melanoma

Locations

HCRN-HOG-10

Phase II Study of Cimetidine in Patients with Metastatic Malignant Melanoma

Status

Closed

Cancer Types

Melanoma

Locations